ReShape Lifesciences's total assets for Q4 2024 were $4.79M, a decrease of -14.64% from the previous quarter. RSLS total liabilities were $5.05M for the fiscal quarter, a 22.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.